Atlas Trials

Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer

Clinical trial NCT02560038 · TERMINATED

Trial details

NCT number
NCT02560038
Sponsor
The University of Texas Health Science Center, Houston
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Urinary Bladder Neoplasms
Start date
2015-10-01
Primary completion
2017-09-14
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.